← Leaderboards
Charles Hebert
Southern Research Institute
$35,247,737
Attributed
$35,247,737
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.7M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$35,678,185 · 5
By mechanism
N01$35,247,737 · 4
U42$430,448 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsExposure ToEarly Life ExposureToxic EffectDisorder PreventionDesignAdverse EffectsNational Toxicology ProgramPublic Health ResearchToxicity TestsHazardous ChemicalsAnimalsPubertyOvaryTestisLifeInfertilityFetal DevelopmentMaterials TestingReproductive OrganBirthLaboratory MiceLaboratory RatAdult
Grant awards (39)
AIDS Subproject 4$400,000
N01 · FY2023 · ES · contact PI
AIDS Combination Therapy Subproject 2$220,000
N01 · FY2023 · ES · contact PI
AIDS Subproject: Resveratrol Subproject 3$200,000
N01 · FY2023 · ES · contact PI
AIDS Tricombination Therapies Subproject 1$180,000
N01 · FY2023 · ES · contact PI
AIDS Combination Therapy Subproject 2$700,000
N01 · FY2022 · ES · contact PI
AIDS Tricombination Therapies Subproject 1$700,000
N01 · FY2022 · ES · contact PI
AIDS Subproject: Resveratrol Subproject 3$400,000
N01 · FY2022 · ES · contact PI
AIDS Subproject 4$400,000
N01 · FY2022 · ES · contact PI
AIDS Tricombination Therapies Subproject 1$700,000
N01 · FY2021 · ES · contact PI
AIDS Resveratrol Subproject 2$700,000
N01 · FY2021 · ES · contact PI
AIDS Subproject: Resveratrol Subproject 3$500,000
N01 · FY2021 · ES · contact PI
AIDS Subproject 4$100,000
N01 · FY2021 · ES · contact PI
AIDS Subproject: Resveratrol Subproject 3$1,000,000
N01 · FY2020 · ES · contact PI
AIDS Resveratrol Subproject 2$1,000,000
N01 · FY2020 · ES · contact PI
AIDS Tricombination Therapies Subproject 1$1,000,000
N01 · FY2020 · ES · contact PI
AIDS Tricombination Therapies Subproject 1$2,400,000
N01 · FY2019 · ES · contact PI
AIDS Resveratrol Subproject 2$1,549,000
N01 · FY2019 · ES · contact PI
IGF::OT::IGF Task Order #2 for "Continuous Rodent and Non-Rodent Pharmacokinetic Assessments"$346,478
N01 · FY2019 · DA · contact PI
Other Projects, Deoxynivalenol Subproject 3$215,387
N01 · FY2019 · ES · contact PI
IGF::OT::IGF TASK ORDER #001 PERFORMANCE AREA 1 MANAGEMENT AND OPERATIONS SUPPORT$103,213
N01 · FY2019 · DA · contact PI
AIDS Tricombination Therapies Subproject 1$2,400,000
N01 · FY2018 · ES · contact PI
AIDS Resveratrol Subproject 2$1,549,000
N01 · FY2018 · ES · contact PI
Other Projects, Deoxynivalenol Subproject 3$399,988
N01 · FY2018 · ES · contact PI
IGF::OT::IGF TASK ORDER #001 PERFORMANCE AREA 1 MANAGEMENT AND OPERATIONS SUPPORT$100,208
N01 · FY2018 · DA · contact PI
IGF::OT::IGF Task Order #2 for "Continuous Rodent and Non-Rodent Pharmacokinetic Assessments"$82,419
N01 · FY2018 · DA · contact PI
AIDS Tricombination Therapies Subproject 1$2,400,000
N01 · FY2017 · ES · contact PI
AIDS Resveratrol Subproject 2$1,549,000
N01 · FY2017 · ES · contact PI
Other Projects, Microcystin Subproject 3$400,000
N01 · FY2017 · ES · contact PI
IGF::OT::IGF Task Order #2 for "Continuous Rodent and Non-Rodent Pharmacokinetic Assessments"$253,062
N01 · FY2017 · DA · contact PI
IGF::OT::IGF TASK ORDER #001 PERFORMANCE AREA 1 MANAGEMENT AND OPERATIONS SUPPORT$97,279
N01 · FY2017 · DA · contact PI
Evaluate Toxicity Following Early Life Exposure$3,949,000
N01 · FY2016 · ES · contact PI
Support of the Research Effort to Evaluate Toxicity Following Early Life Exposure to Test Articles for the NTP$251,000
N01 · FY2016 · ES · contact PI
IGF::OT::IGF TASK ORDER #001 PERFORMANCE AREA 1 MANAGEMENT AND OPERATIONS SUPPORT$113,499
N01 · FY2016 · DA · contact PI
Evaluate Toxicity Following Early Life Exposure$3,949,000
N01 · FY2015 · ES · contact PI
Support of the Research Effort to Evaluate Toxicity Following Early Life Exposure to Test Articles for the NTP$251,000
N01 · FY2015 · ES · contact PI
IGF::OT::IGF CONTRACTOR ORIENTATION AND KICKOFF MEETING FOR SRI$2,637
N01 · FY2015 · CA · contact PI
IGF::OT::IGFSupport of the Research Effort to Evaluate Toxicity Following Early Life Exposure to Test Articles for the NTP$4,000,000
N01 · FY2014 · ES · contact PI
Preclinical Pharmacology and Toxicology Studies$686,567
N01 · FY2009 · CA · contact PI
CORE SUPPORT AS AN NGVL TOXICOLOGY CENTER$430,448
U42 · FY2005 · RR